# Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial

> **NCT01149369** · PHASE2 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 126 (actual)

## Conditions studied

- Gastroparesis

## Interventions

- **DRUG:** Aprepitant
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01149369
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2015-08
- **Final completion:** 2015-09
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2019-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01149369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01149369, "Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01149369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*